COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
The Centers for Disease Control and Prevention recently posted updated considerations for ending isolation for adults with COVID-19, based on new evidence.
When ordering COVID-19 laboratory tests or collecting specimens, health care providers should collect certain patient demographic information and responses to certain questions needed for COVID-19 data reporting, according to updated guidance from the Centers for Disease Control and Prevention.
The Department of Health and Human Services (HHS) this week shared additional information on reporting requirements for recipients of provider relief funds authorized under the Coronavirus Aid, Relief, and Economic Security (CARES) Act and Paycheck Protection Program and Health Care Enhancement Act…
An estimated 2.8% of Indiana residents aged 12 or older randomly tested in late April had SARS-CoV-2 infection or antibodies, and 44% of those with active infections reported no symptoms, according to a July 21 report released by the Centers for Disease Control and Prevention.
The Food and Drug Administration last week reissued its emergency use authorization of Quest Diagnostics’ SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to four individual swab specimens collected under observation.
The New England Journal of Medicine last week released a study showing that the use of dexamethasone resulted in a lower, 28-day mortality rate among patients receiving invasive ventilation or oxygen.
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response July 21 at 12 p.m. ET will host a COVID-19 webinar on “Critical Care: Lifesaving Treatment and Clinical Operations.”
The Food and Drug Administration at 8 p.m. will close its COVID-19 hotline for questions related to COVID-19 diagnostic tests and device shortages, including personal protective equipment and respirators.
The Centers for Disease Control and Prevention is developing guidance that will no longer recommend a second negative test within 24 hours before COVID-19 patients emerge from isolation, according to news reports from a press call with Brett Giroir, M.D., assistant secretary for health at the…
The Food and Drug Administration added to its FAQs on testing for SARS-CoV-2 a list of laboratories that should no longer be used.